Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 350 of 3173 entries
View as:

A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.

Phase: N/A Priority: Normal
NCT ID: NCT00625833 Org: User:
Start: 12/31/07 End: 11/30/08 Due: 11/30/09

Monitoring Activity And Gait In Children

Phase: N/A Priority: Normal
NCT ID: NCT04823650 Org: User:
Start: 08/23/21 End: 10/28/24 Due: 10/28/25

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

Phase: N/A Priority: Normal
NCT ID: NCT06592222 Org: User:
Start: 08/26/24 End: 03/03/25 Due: 03/03/26

Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01112865 Org: User:
Start: 08/31/10 End: 10/31/11 Due: 10/31/12

A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05391061 Org: User:
Start: 01/07/23 End: 11/22/27 Due: 11/22/28

Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04362072 Org: User:
Start: 09/29/20 End: 10/23/24 Due: 10/23/25

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT01335061 Org: User:
Start: 09/30/11 End: 04/30/14 Due: 04/30/15

Cost Effectiveness Of Sunitinib In Central America And Caribbean

Phase: N/A Priority: Normal
NCT ID: NCT01033981 Org: User:
Start: 05/31/10 End: 02/28/11 Due: 02/28/12

A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT05387980 Org: User:
Start: 04/19/22 End: 08/02/28 Due: 08/02/29

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT00643227 Org: User:
Start: 01/31/03 End: 03/31/04 Due: 03/31/05

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

Phase: N/A Priority: Normal
NCT ID: NCT05721937 Org: User:
Start: 07/25/23 End: 12/31/27 Due: 12/31/28

Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00078468 Org: User:
Start: 12/31/03 End: 09/30/04 Due: 09/30/05

Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT05263895 Org: User:
Start: 03/03/22 End: 05/16/22 Due: 05/16/23

A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan

Phase: N/A Priority: Normal
NCT ID: NCT06864585 Org: User:
Start: 09/15/25 End: 03/30/29 Due: 03/30/30

A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT06671834 Org: User:
Start: 11/22/24 End: 10/15/25 Due: 10/15/26

Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00254904 Org: User:
Start: 11/30/05 End: 06/30/08 Due: 06/30/09

Sayana-Uniject Volumetric Delivery

Phase: N/A Priority: Normal
NCT ID: NCT01298479 Org: User:
Start: 05/31/10 End: 06/30/10 Due: 06/30/11

A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco

Phase: N/A Priority: Normal
NCT ID: NCT05997485 Org: User:
Start: 03/30/24 End: 06/30/24 Due: 06/30/25

A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01937715 Org: User:
Start: 02/28/14 End: 08/31/15 Due: 08/31/16

Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05037409 Org: User:
Start: 09/28/21 End: 03/27/22 Due: 03/27/23

ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01360554 Org: User:
Start: 06/16/11 End: 09/14/15 Due: 09/14/16

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05796245 Org: User:
Start: 12/01/23 End: 03/14/24 Due: 03/14/25

Study of GBT021601 in Participants With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05878704 Org: User:
Start: 06/29/23 End: 07/29/24 Due: 07/29/25

The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02570750 Org: User:
Start: 05/07/15 End: 12/05/16 Due: 12/05/17

A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05930925 Org: User:
Start: 06/12/23 End: 08/14/23 Due: 08/14/24